{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:29:04Z","timestamp":1779247744010,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["_MU_UU_00014\/40"],"award-info":[{"award-number":["_MU_UU_00014\/40"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210755\/Z\/18\/Z"],"award-info":[{"award-number":["210755\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eprac.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T11:18:33Z","timestamp":1751714313000},"page":"1395-1398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone \u03b2"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0749-7411","authenticated-orcid":false,"given":"Timothy M.E.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis","family":"Bryden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.07.001_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cen.14817","article-title":"Genetic disorders of thyroid development, hormone biosynthesis and signalling","volume":"97","author":"Moran","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2025.07.001_bib2","doi-asserted-by":"crossref","first-page":"e2005","DOI":"10.1210\/clinem\/dgab002","article-title":"Dyslipidemia, insulin resistance, ectopic lipid accumulation, and vascular function in resistance to thyroid hormone beta","volume":"106","author":"Moran","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.001_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2265.2008.03422.x","article-title":"Augmentation index in resistance to thyroid hormone (RTH)","volume":"70","author":"Owen","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2025.07.001_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.eprac.2025.07.001_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf023","article-title":"Cardiovascular risk and plasma N-terminal pro-B-type natriuretic peptide in adults with resistance to thyroid hormone beta","volume":"9","author":"Davis","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.eprac.2025.07.001_bib6","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1073\/pnas.0608537103","article-title":"Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men","volume":"103","author":"Petersen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eprac.2025.07.001_bib7","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.07.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102581","article-title":"Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride\/glucose index","volume":"16","author":"Tahapary","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.eprac.2025.07.001_bib9","article-title":"The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome","volume":"10","author":"Biernacka-Bartnik","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.eprac.2025.07.001_bib10","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.3390\/ijerph111010663","article-title":"Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status","volume":"11","author":"Downer","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eprac.2025.07.001_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1758-5996-2-28","article-title":"Comparison of body mass index and waist circumference as predictors of cardiometabolic health in a population of young Canadian adults","volume":"2","author":"Brenner","year":"2010","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.eprac.2025.07.001_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2025.07.001_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9343(01)00980-9","article-title":"Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction","volume":"111","author":"Friberg","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.eprac.2025.07.001_bib14","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1172\/JCI107017","article-title":"Plasma triglyceride metabolism in thyroid disease","volume":"51","author":"Nikkila","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eprac.2025.07.001_bib15","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jcem.86.11.7981","article-title":"Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients","volume":"86","author":"Cachefo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.001_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1258\/000456305774538247","article-title":"Plasma non-esterified fatty acids: why are we not measuring them routinely?","volume":"42","author":"Frayn","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.eprac.2025.07.001_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2017.02.029","article-title":"Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes","volume":"458","author":"Groeneweg","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.001_bib18","first-page":"901","article-title":"Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects","volume":"75","author":"Sherman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.001_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-8587(23)00155-9","article-title":"Cardiovascular morbidity and mortality in patients in Wales, UK with resistance to thyroid hormone beta (RTHbeta): a linked-record cohort study","volume":"11","author":"Okosieme","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.001_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11886-001-0059-0","article-title":"Pathophysiology and treatment of the dyslipidemia of insulin resistance","volume":"3","author":"Cohn","year":"2001","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.eprac.2025.07.001_bib21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.mcna.2007.06.008","article-title":"Treatment of the dyslipidemia of insulin resistance","volume":"91","author":"Smith","year":"2007","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.eprac.2025.07.001_bib22","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2025.07.001_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1258\/000456306778904678","article-title":"Thyroid hormone resistance","volume":"43","author":"Olateju","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.eprac.2025.07.001_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34836","article-title":"Surrogate adiposity markers and mortality","volume":"6","author":"Khan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eprac.2025.07.001_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9241904","article-title":"Anthropometrics, metabolic syndrome, and mortality hazard","volume":"2018","author":"Krakauer","year":"2018","journal-title":"J Obes"},{"key":"10.1016\/j.eprac.2025.07.001_bib26","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2025.07.001_bib27","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1093\/eurheartj\/ehae471","article-title":"Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial","volume":"45","author":"Nurmohamed","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:37:00Z","timestamp":1768401420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1530891X25009449"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone \u03b2","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}